Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

876
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
876
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

2.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
2.7K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

388
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
388

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Caring for Australians and New ZealandeRs with kidney Impairment guideline commentary on kidney disease: improving global outcomes 2025 guidelines for diagnosis and management of autosomal polycystic kidney disease.

Internal medicine journal·2026
Same author

Nutritional adequacy of ketogenic diets as a novel dietary intervention for people living with autosomal dominant polycystic kidney disease.

Journal of nephrology·2026
Same author

Impact of Zinc Supplementation in Adults With Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Nutrition reviews·2026
Same author

Sequence Variants in Small CAG Repeat Expansions of the <i>HTT</i> Gene and Disease Onset and Progression in Huntington Disease.

Neurology·2025
Same author

Social Attention Through a New Lens: Autistic and ADHD Traits and Eye Occlusion Affect Gaze During Conversation Watching.

Quarterly journal of experimental psychology (2006)·2025
Same author

Beyond the Malnutrition Screening Tool: Assessing Hand Grip Strength and Gastrointestinal Symptoms for Malnutrition Prediction in Outpatients with Chronic Kidney Disease Not on Kidney Replacement Therapy.

Nutrients·2025

Related Experiment Video

Updated: May 8, 2025

Routine Screening Method for Microparticles in Platelet Transfusions
09:49

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

15.8K

Blood platelet inventory management: Incorporating data-driven demand forecasts.

Maryam Motamedi1, Jessica Dawson1, Na Li1,2,3

  • 1Department of Computing and Software, McMaster University, Hamilton, L8S 4L8, Ontario, Canada.

Health Care Management Science
|May 2, 2025
PubMed
Summary

This study introduces a data-driven model for managing platelet inventory, aiming to reduce shortages and waste. The findings show that incorporating demand forecasts improves inventory management, even with forecast errors.

Keywords:
Base stockData-driven optimizationForecastingHealth serviceInventory managementOperations managementOperations researchPlatelet inventory management

More Related Videos

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

706
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

13.7K

Related Experiment Videos

Last Updated: May 8, 2025

Routine Screening Method for Microparticles in Platelet Transfusions
09:49

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

15.8K
Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

706
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

13.7K

Area of Science:

  • Operations Research
  • Healthcare Management
  • Supply Chain Optimization

Background:

  • Platelet products are critical for treating severe diseases like cancer but are expensive with short shelf lives.
  • Managing platelet inventory is challenging due to uncertain and highly variable demand.
  • Current inventory management strategies struggle to balance minimizing shortages and wastage effectively.

Purpose of the Study:

  • To develop and evaluate a data-driven inventory management model for platelet products.
  • To incorporate demand forecasts into inventory management to optimize ordering policies.
  • To minimize both platelet shortages and wastage within the blood transfusion system.

Main Methods:

  • Developed a novel inventory management model utilizing demand forecasts for platelet products.
  • Employed forecast-dependent target inventory levels to guide the ordering policy.
  • Utilized a large clinical dataset of daily platelet transfusions from 2016-2018 for a centralized blood distribution center serving four hospitals.

Main Results:

  • The proposed data-driven policy effectively minimizes both shortages and wastage of platelet products.
  • The model demonstrates resilience, tolerating larger forecast errors as system scale increases (e.g., via demand aggregation and inventory pooling).
  • Sensitivity analysis confirms the model's robustness and suggests feasibility of less frequent than daily ordering.

Conclusions:

  • Incorporating demand forecasts into inventory management significantly improves platelet product supply chain efficiency.
  • The developed model offers a practical solution for reducing costs associated with platelet wastage and shortages.
  • This approach supports more sustainable and reliable blood transfusion services.